Featured awards of Giulio Francia
SC1: THE ROLE OF BREAST CANCER ORGAN SPECIFIC METASTASIS ON THE THERAPEUTIC IMPACT OF ANTI-CANCER DRUGS
Start Date: 5-1-2020
End Date: 4-30-2024
Sponsor: NIH - NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
PRECLINICAL MODELS OF CIRCULATING COLON CANCER CELLS TO EVALUATE ANTI-CANCER THERAPIES
Start Date: 7-1-2016
End Date: 6-30-2017
Sponsor: NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES THROUGH TUSKEGEE UNIVERSITY
EVALUATION OF METRONOMIC CHEMOTHERAPY REGIMENS IN OVARIAN CANCER MODELS
Start Date: 7-1-2016
End Date: 6-30-2017
Sponsor: NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES THROUGH UNIVERSITY OF HAWAII
SC2 PACLITAXEL DIRECTED DRUG SCREENING: A NEW STRATEGY TO IDENTIFY ANTI-CANCER DRUGS
Start Date: 8-16-2016
End Date: 7-31-2019
Sponsor: NATIONAL CANCER INSTITUTE
SC2: PACLITAXEL DIRECTED DRUG SCREENING: A NEW STRATEGY TO IDENTIFY ANTI-CANCER DRUGS
Start Date: 8-16-2016
End Date: 7-31-2019
Sponsor: NIH - NATIONAL CANCER INSTITUTE
Start Date: 5-1-2020
End Date: 4-30-2024
Sponsor: NIH - NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
PRECLINICAL MODELS OF CIRCULATING COLON CANCER CELLS TO EVALUATE ANTI-CANCER THERAPIES
Start Date: 7-1-2016
End Date: 6-30-2017
Sponsor: NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES THROUGH TUSKEGEE UNIVERSITY
EVALUATION OF METRONOMIC CHEMOTHERAPY REGIMENS IN OVARIAN CANCER MODELS
Start Date: 7-1-2016
End Date: 6-30-2017
Sponsor: NATIONAL INSTITUTE ON MINORITY HEALTH AND HEALTH DISPARITIES THROUGH UNIVERSITY OF HAWAII
SC2 PACLITAXEL DIRECTED DRUG SCREENING: A NEW STRATEGY TO IDENTIFY ANTI-CANCER DRUGS
Start Date: 8-16-2016
End Date: 7-31-2019
Sponsor: NATIONAL CANCER INSTITUTE
SC2: PACLITAXEL DIRECTED DRUG SCREENING: A NEW STRATEGY TO IDENTIFY ANTI-CANCER DRUGS
Start Date: 8-16-2016
End Date: 7-31-2019
Sponsor: NIH - NATIONAL CANCER INSTITUTE
